Comet Bio Denmark ApS: Financial statements 2023
CVR: 43297333
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Comet Bio Denmark ApS (CVR 43297333) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -50,706,731 and a net result of DKK -65,764,641. Equity in the 2023 report amounted to DKK -69,757,625. The company had 2 employees in the financial year.
- Gross Profit
- DKK -50,706,731
- Profit/Loss
- DKK -65,764,641
- Equity
- DKK -69,757,625
- Total Assets
- DKK 39,339,538
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 14, 2023, Stephen Jonathan Jones is registered as director of Comet Bio Denmark ApS.
As of November 14, 2023, Richard Lloyd Troyer has stepped down as director of Comet Bio Denmark ApS.
Comet Bio Denmark ApS has published its interim report for the period May 9, 2022 – December 31, 2022.
About Comet Bio Denmark ApS
Comet Bio Denmark ApS is a Danish company of the type Anpartsselskab based in Kalundborg, founded in 2022. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Loula Sassaris Merkel. The company is owned by Comet Biorefining Inc.. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 3,693 and a net result of DKK -161,466 compared with DKK 51,637,070 the year before. Equity in the 2025 report amounted to DKK -18,282,021.